Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1109

1.

Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.

Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF.

Pediatrics. 2009 Aug;124(2):580-9. doi: 10.1542/peds.2008-2569. Epub 2009 Jul 27.

PMID:
19651580
3.

How parents make decisions to use medication to treat their child's ADHD: a grounded theory study.

Cormier E.

J Am Psychiatr Nurses Assoc. 2012 Nov-Dec;18(6):345-56. doi: 10.1177/1078390312466918. Epub 2012 Nov 13.

PMID:
23149857
4.

Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder.

Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC.

J Dev Behav Pediatr. 2003 Jun;24(3):155-62.

PMID:
12806227
5.
6.

Investigating ADHD treatment trajectories: listening to families' stories about medication use.

Leslie LK, Plemmons D, Monn AR, Palinkas LA.

J Dev Behav Pediatr. 2007 Jun;28(3):179-88.

PMID:
17565284
7.

Review of medication adherence in children and adults with ADHD.

Adler LD, Nierenberg AA.

Postgrad Med. 2010 Jan;122(1):184-91. doi: 10.3810/pgm.2010.01.2112. Review.

PMID:
20107302
8.

National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS.

J Clin Psychiatry. 2008 Jan;69(1):131-40.

PMID:
18312048
9.
10.
11.

Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.

Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.

Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.

12.

Practice guidelines and parental ADHD treatment evaluations: friends or foes?

Bussing R, Gary FA.

Harv Rev Psychiatry. 2001 Sep-Oct;9(5):223-33.

PMID:
11553526
13.

Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):226-37. doi: 10.1089/cap.2011.0090. Epub 2012 Apr 26.

14.

Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model.

dosReis S, Myers MA.

Int Rev Psychiatry. 2008 Apr;20(2):135-41. doi: 10.1080/09540260801933084. Review.

PMID:
18386203
15.

Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.

Johnston C, Seipp C, Hommersen P, Hoza B, Fine S.

Child Care Health Dev. 2005 Nov;31(6):669-77.

PMID:
16207224
16.

Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.

Saylor KE, Buermeyer CM, Spencer TJ, Barkley RA.

J Clin Psychiatry. 2002;63 Suppl 12:23-8. Review.

PMID:
12562058
17.

Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics.

Johnston C, Hommersen P, Seipp C.

Behav Ther. 2008 Mar;39(1):22-32. doi: 10.1016/j.beth.2007.04.002. Epub 2007 Oct 18.

PMID:
18328867
18.

Management of attention deficit hyperactivity disorder: a parental perspective.

Concannon PE, Tang YP.

J Paediatr Child Health. 2005 Dec;41(12):625-30.

PMID:
16398864
19.

Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.

Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S.

Med Decis Making. 2005 Jan-Feb;25(1):56-70.

PMID:
15673582
20.

Supplemental Content

Support Center